Skip to main content
. 2021 May 22;2021(5):CD012721. doi: 10.1002/14651858.CD012721.pub3

Dielievska 2015.

Methods Individual, two‐arm, RCT
Participants 80 participants with EHT and COPD of ll‐lll grade of bronchial obstruction (GOLD 2‐3) with chronic heart failure of the II and III NYHA classes and evidence of diastolic dysfunction
Interventions Spironolactone versus standard therapy, 3 months
Outcomes Left ventricular diastolic function, impaired relaxation of left ventricle, adverse events
Notes Have not yet obtained full text